Immunotherapy: PD-1 Antibodies and Beyond- Dr. Carvajal Melanoma Education Symposium 2014
5 意见
• 07/30/23
0
0
嵌入
Dr. Carvajal, Director of Developmental Therapeutics and Assistant Attending Physician at Memorial Sloan Kettering Cancer Center describes the future of immunotherapy and clinical trials for metastatic melanoma.
Agency: BoldSpark
Director: Sean Willis
BoldSparkCollective.com
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论